Mon, 27 Apr 2009 14:59:48 -0400 PeerView Urology CME/CNE/CPE Audio Podcast PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY, 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/urology/podcast_urologyCME-CNE-CPE_144.jpg PeerView Urology CME/CNE/CPE Audio Podcast http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE no Laura S. Wood, RN, MSN, OCN - Early and Aggressive Management of Treatment-Related Adverse Effects Is Essential for Achieving Optimal Clinical Outcome With Targeted Therapies in Patients With Kidney Cancer PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this program, an expert on kidney cancer provides a concise summary of the key aspects of the biology of renal cell carcinoma (RCC), characteristics of the targeted therapies, and strategies to effectively manage the adverse effects related to these agents. http://podcast.peerviewpress.com/Urology/PA05122FCn205.mp3 http://podcast.peerviewpress.com/urology/PA05122FCn205.mp3 Tue, 10 Mar 2009 16:13:46 -0400 Science, Medicine no 00:18:59 renal cell, targeted, kidney, RCC, mTOR, antiangiogenesis, bevacizumab, sunitinib, everolimus, temsirolimus, sorafenib CME/CNE/CPE Information - Early and Aggressive Management of Treatment-Related Adverse Effects Is Essential for Achieving Optimal Clinical Outcome With Targeted Therapies in Patients With Kidney Cancer PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Urology/PA05122FCCMEinfo.pdf http://podcast.peerviewpress.com/urology/PA05122FCCMEinfo.pdf Tue, 10 Mar 2009 16:13:43 -0400 Science, Medicine no 00:00:00 renal cell, targeted, kidney, RCC, mTOR, antiangiogenesis, bevacizumab, sunitinib, everolimus, temsirolimus, sorafenib Roger R. Dmochowski, MD - Challenges in Managing Overactive Bladder: A Case-Based Approach PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, an expert in the management of overactive bladder discusses diagnosis and treatment of this condition using a case-based format. Management strategies for a patient with comorbidities are also highlighted. http://podcast.peerviewpress.com/Urology/PA04407FCp138.mp3 http://podcast.peerviewpress.com/Urology/PA04407FCp138.mp3 Thu, 29 May 2008 17:39:52 -0400 Science & Medicine no 00:27:25 Incontinence, overactive bladder, micturition, voiding, antimuscarinic, urgency, nocturia, UTI, Kegel, bladder, LUTS CME/CE Information - Challenges in Managing Overactive Bladder: A Case-Based Approach PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Urology/PA04407FCCMEinfo.pdf http://podcast.peerviewpress.com/Urology/PA04407FCCMEinfo.pdf Thu, 29 May 2008 17:38:53 -0400 Science & Medicine no 00:00:00 Incontinence, overactive bladder, micturition, voiding, antimuscarinic, urgency, nocturia, UTI, Kegel, bladder, LUTS Ronald de Wit, MD - Educational Interventions to Improve Outcomes in the Multidisciplinary Treatment of Hormone-Refractory Prostate Cancer PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, experts in the treatment of hormone-refractory prostate cancer present recent data on chemotherapeutic regimens, selection of patients for treatment, and prognostic factors for survival. Multidisciplinary management of this condition is also discussed. http://podcast.peerviewpress.com/Urology/PA03939FCr343.mp3 http://podcast.peerviewpress.com/Urology/PA03939FCr343.mp3 Fri, 19 Oct 2007 13:52:44 -0400 Science & Medicine no 00:40:56 prostate cancer,hormone-refractory rostate cancer, HRPC, hormonal manipulation, androgen deprivation, antiandrogen therapy, orchiectomy,docetaxel, mitoxantrone, estramustine, prednisone CME/CE - Educational Interventions to Improve Outcomes in the Multidisciplinary Treatment of Hormone-Refractory Prostate Cancer PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Urology/PA03939FCCMEinfo.pdf http://podcast.peerviewpress.com/Urology/PA03939FCCMEinfo.pdf Fri, 19 Oct 2007 13:52:38 -0400 Science & Medicine no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE